253 related articles for article (PubMed ID: 32144727)
41. A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice.
Pérez P; Q Marín M; Lázaro-Frías A; Jiménez de Oya N; Blázquez AB; Escribano-Romero E; S Sorzano CÓ; Ortego J; Saiz JC; Esteban M; Martín-Acebes MA; García-Arriaza J
Sci Rep; 2018 Nov; 8(1):17385. PubMed ID: 30478418
[TBL] [Abstract][Full Text] [Related]
42. Zika virus-induced acute myelitis and motor deficits in adult interferon αβ/γ receptor knockout mice.
Zukor K; Wang H; Siddharthan V; Julander JG; Morrey JD
J Neurovirol; 2018 Jun; 24(3):273-290. PubMed ID: 29476408
[TBL] [Abstract][Full Text] [Related]
43. Gist of Zika Virus pathogenesis.
Bhardwaj U; Pandey N; Rastogi M; Singh SK
Virology; 2021 Aug; 560():86-95. PubMed ID: 34051478
[TBL] [Abstract][Full Text] [Related]
44. Human Schwann cells are susceptible to infection with Zika and yellow fever viruses, but not dengue virus.
Dhiman G; Abraham R; Griffin DE
Sci Rep; 2019 Jul; 9(1):9951. PubMed ID: 31289325
[TBL] [Abstract][Full Text] [Related]
45. An Immunocompetent Mouse Model of Zika Virus Infection.
Gorman MJ; Caine EA; Zaitsev K; Begley MC; Weger-Lucarelli J; Uccellini MB; Tripathi S; Morrison J; Yount BL; Dinnon KH; Rückert C; Young MC; Zhu Z; Robertson SJ; McNally KL; Ye J; Cao B; Mysorekar IU; Ebel GD; Baric RS; Best SM; Artyomov MN; Garcia-Sastre A; Diamond MS
Cell Host Microbe; 2018 May; 23(5):672-685.e6. PubMed ID: 29746837
[TBL] [Abstract][Full Text] [Related]
46. Zika Virus Targeting in the Developing Brain.
van den Pol AN; Mao G; Yang Y; Ornaghi S; Davis JN
J Neurosci; 2017 Feb; 37(8):2161-2175. PubMed ID: 28123079
[TBL] [Abstract][Full Text] [Related]
47. Zika infection and the development of neurological defects.
Russo FB; Jungmann P; Beltrão-Braga PCB
Cell Microbiol; 2017 Jun; 19(6):. PubMed ID: 28370966
[TBL] [Abstract][Full Text] [Related]
48. Zika-virus-infected human full-term placental explants display pro-inflammatory responses and undergo apoptosis.
Ribeiro MR; Moreli JB; Marques RE; Papa MP; Meuren LM; Rahal P; de Arruda LB; Oliani AH; Oliani DCMV; Oliani SM; Narayanan A; Nogueira ML
Arch Virol; 2018 Oct; 163(10):2687-2699. PubMed ID: 29876782
[TBL] [Abstract][Full Text] [Related]
49. ZIKV infection activates the IRE1-XBP1 and ATF6 pathways of unfolded protein response in neural cells.
Tan Z; Zhang W; Sun J; Fu Z; Ke X; Zheng C; Zhang Y; Li P; Liu Y; Hu Q; Wang H; Zheng Z
J Neuroinflammation; 2018 Sep; 15(1):275. PubMed ID: 30241539
[TBL] [Abstract][Full Text] [Related]
50. Atlastin Endoplasmic Reticulum-Shaping Proteins Facilitate Zika Virus Replication.
Monel B; Rajah MM; Hafirassou ML; Sid Ahmed S; Burlaud-Gaillard J; Zhu PP; Nevers Q; Buchrieser J; Porrot F; Meunier C; Amraoui S; Chazal M; Salles A; Jouvenet N; Roingeard P; Blackstone C; Amara A; Schwartz O
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534046
[TBL] [Abstract][Full Text] [Related]
51. Impact of Zika virus on the human type I interferon osteoimmune response.
Drouin A; Wallbillich N; Theberge M; Liu S; Katz J; Bellovoda K; Se Yun Cheon S; Gootkind F; Bierman E; Zavras J; Berberich MJ; Kalocsay M; Guastaldi F; Salvadori N; Troulis M; Fusco DN
Cytokine; 2021 Jan; 137():155342. PubMed ID: 33130337
[TBL] [Abstract][Full Text] [Related]
52. Fibroblast Growth Factor 2 Enhances Zika Virus Infection in Human Fetal Brain.
Limonta D; Jovel J; Kumar A; Lu J; Hou S; Airo AM; Lopez-Orozco J; Wong CP; Saito L; Branton W; Wong GK; Mason A; Power C; Hobman TC
J Infect Dis; 2019 Sep; 220(8):1377-1387. PubMed ID: 30799482
[TBL] [Abstract][Full Text] [Related]
53. Hydroxycarboxylic Acid Receptor 2 Is a Zika Virus Restriction Factor That Can Be Induced by Zika Virus Infection Through the IRE1-XBP1 Pathway.
Ma X; Luo X; Zhou S; Huang Y; Chen C; Huang C; Shen L; Zhang P; Liu C
Front Cell Infect Microbiol; 2019; 9():480. PubMed ID: 32039055
[TBL] [Abstract][Full Text] [Related]
54. Molecular and cellular insights into Zika virus-related neuropathies.
Zhou K; Wang L; Yu D; Huang H; Ji H; Mo X
J Neurovirol; 2017 Jun; 23(3):341-346. PubMed ID: 28127671
[TBL] [Abstract][Full Text] [Related]
55. Gain-of-function genetic screening identifies the antiviral function of TMEM120A via STING activation.
Li S; Qian N; Jiang C; Zu W; Liang A; Li M; Elledge SJ; Tan X
Nat Commun; 2022 Jan; 13(1):105. PubMed ID: 35013224
[TBL] [Abstract][Full Text] [Related]
56. Zika Virus Production Is Resistant to RNase L Antiviral Activity.
Whelan JN; Li Y; Silverman RH; Weiss SR
J Virol; 2019 Aug; 93(16):. PubMed ID: 31142667
[TBL] [Abstract][Full Text] [Related]
57. Skeletal Muscle Is an Early Site of Zika Virus Replication and Injury, Which Impairs Myogenesis.
Gavino-Leopoldino D; Figueiredo CM; da Silva MOL; Barcellos LG; Neris RLS; Pinto LDM; Araújo SMB; Ladislau L; Benjamim CF; Da Poian AT; Clarke JR; Figueiredo CP; Assunção-Miranda I
J Virol; 2021 Oct; 95(22):e0090421. PubMed ID: 34468171
[TBL] [Abstract][Full Text] [Related]
58. Zika Virus Subgenomic Flavivirus RNA Generation Requires Cooperativity between Duplicated RNA Structures That Are Essential for Productive Infection in Human Cells.
Pallarés HM; Costa Navarro GS; Villordo SM; Merwaiss F; de Borba L; Gonzalez Lopez Ledesma MM; Ojeda DS; Henrion-Lacritick A; Morales MA; Fabri C; Saleh MC; Gamarnik AV
J Virol; 2020 Aug; 94(18):. PubMed ID: 32581095
[TBL] [Abstract][Full Text] [Related]
59. A global lipid map defines a network essential for Zika virus replication.
Leier HC; Weinstein JB; Kyle JE; Lee JY; Bramer LM; Stratton KG; Kempthorne D; Navratil AR; Tafesse EG; Hornemann T; Messer WB; Dennis EA; Metz TO; Barklis E; Tafesse FG
Nat Commun; 2020 Jul; 11(1):3652. PubMed ID: 32694525
[TBL] [Abstract][Full Text] [Related]
60. Zika Virus: Immune Evasion Mechanisms, Currently Available Therapeutic Regimens, and Vaccines.
Asif A; Manzoor S; Tuz-Zahra F; Saalim M; Ashraf M; Ishtiyaq J; Khalid M
Viral Immunol; 2017 Dec; 30(10):682-690. PubMed ID: 29028178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
